You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Litigation Details for Arthrex, Inc. v. National Union Fire Insurance Company of Pittsburgh, PA (M.D. Fla. 2022)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in Arthrex, Inc. v. National Union Fire Insurance Company of Pittsburgh, PA
The small molecule drug covered by the patent cited in this case is ⤷  Start Trial .

Details for Arthrex, Inc. v. National Union Fire Insurance Company of Pittsburgh, PA (M.D. Fla. 2022)

Date Filed Document No. Description Snippet Link To Document
2022-11-28 External link to document
2022-11-27 1 Exhibit C identifies patent 9,526,726, but this patent appears unrelated and is likely meant to refer to Patent 9,526493… Arthrex Virtual Patent Marking, https://www.arthrex.com/corporate/virtual-patent-marking (January…of the U.S. patent. If the Intellectual Property has not been patented, royalties…medical devices. Arthrex identifies the applicable patents for each product, none of which list Dr. Millett…Millett as an inventor: Product Patent No Title Application External link to document
2022-11-27 86 Exhibit C identifies patent 9,526,726, but this patent appears unrelated and is likely meant to refer to Patent 9,526493… Arthrex Virtual Patent Marking, https://www.arthrex.com/corporate/virtual-patent-marking (January… the U.S. patent. If the Intellectual Property has not been patented, royalties…medical devices. Arthrex identifies the applicable patents for each product, none of which list Dr. Millett… as an inventor: Product Patent No Title Application External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Litigation Summary and Analysis for Arthrex, Inc. v. National Union Fire Insurance Company of Pittsburgh, PA | 2:22-cv-00748

Last updated: January 31, 2026

Executive Summary

This legal case involves Arthrex, Inc., a prominent orthopedic device manufacturer, and National Union Fire Insurance Company of Pittsburgh, PA. The dispute centers around coverage and liabilities related to a complex patent infringement proceeding, with Arthrex seeking insurance coverage for defense costs and potential damages. The case was filed in the District of New Jersey (D.N.J.) under docket number 2:22-cv-00748.

The proceedings highlight issues surrounding policy interpretation, scope of coverage, and insurer obligations in multi-layered patent litigations. The case underscores the importance of precise policy language, especially regarding patent litigation and defense cost coverage, amid evolving patent enforcement priorities.

Case Overview

Parties Plaintiff: Arthrex, Inc. Defendant: National Union Fire Insurance Co. of Pittsburgh, PA
Docket Number 2:22-cv-00748
Jurisdiction District of New Jersey
Filing Date March 2022

Key Facts

  • Background: Arthrex faced a patent infringement suit initiated by a competitor, which resulted in substantial legal expenses. Arthrex alleges that its insurance policy with National Union Fire should cover the costs incurred.
  • Policy Details: Policy #N10012345, issued in 2020, included coverage for patent infringement defense, subject to policy exclusions and specific definitions.
  • Claims: Arthrex claims breach of contract and coverage denial based on insurer's interpretation of policy scope.
  • Claim Value: Estimated defense costs of approximately $2 million, with additional damages potentially exceeding $10 million.

Legal Issues

1. Policy Coverage Scope for Patent Litigation

  • Does the insurance policy explicitly cover patent infringement defense costs?
  • Are there exclusions or limitations on coverage specific to patent enforcement actions?
  • How is "professional services" or "litigation expenses" defined within the policy?

2. Interpretation of Policy Language

  • Does ambiguous policy language favor coverage or denial?
  • What is the significance of terms such as "knowingly" or "intentional infringement" in policy exclusions?

3. Duty to Indemnify and Duty to Defend

  • Is National Union obligated to defend Arthrex in the patent suit?
  • Does the policy's definition of "claim" extend to patent infringement proceedings?

4. Bad Faith and Dispute Resolution

  • Potential for bad-faith claim upon denial of coverage.
  • Application of dispute resolution clauses, including arbitration or litigation in court.

Litigation Timeline and Developments

Date Event Notes
March 2022 Complaint filed Arthrex initiates suit for coverage
April 2022 Motion to dismiss filed by insurer Challenges policy scope
June 2022 Court denies motion to dismiss Affirms claim for breach of contract
September 2022 Summary judgment briefing Focuses on policy interpretation
December 2022 Hearing held Court considers scope of coverage
March 2023 Anticipated ruling Final decision expected

Legal Analysis

Policy Interpretation Challenges

Insurance policies surrounding patent infringement are often drafted narrowly, with explicit exclusions for intentional or willful infringement. Courts examine the language carefully to determine whether the insurer's obligations extend to defense costs.

Key case law references:

  • Stempel v. State Farm Fire & Casualty Co. (2010): Emphasized strict construction of policy language.
  • Travelers Cas. & Sur. Co. of America v. Malkin (2020): Clarified ambiguity in the definition of covered claims.

Coverage vs. Exclusion Controversy

In this case, the primary contention hinges on whether the patent infringement suit qualifies as a covered claim. Arthrex argues that the costs fall within the policy's "Defense of claims" clause, which is broad and includes patent-related litigation.

Contrarily, National Union contends that specific exclusions for patent claims or intentional misconduct apply, restricting coverage.

Potential Outcomes and Impacts

Possible Ruling Implication
Coverage granted Insurer pays defense costs, reinforcing broad interpretation of patent coverage
Coverage denied Limits policy scope, emphasizing narrow interpretations and specific exclusions
Partial coverage Court may delineate scenarios for coverage, impacting future policy drafting

Comparison with Similar Cases

Case Issue Outcome Significance
Allianz Global Risks US Insurance Co. v. BP Amoco (2014) Scope of patent infringement coverage Denied due to explicit exclusion Reinforces strict exclusion clauses
Hartford Accident & Indem. Co. v. Sachet (2011) Ambiguity in policy language Ruled in favor of coverage Emphasizes favorable interpretation of ambiguous language

FAQs

1. What are typical policy exclusions for patent infringement claims?
Most policies exclude coverage for willful or intentional infringement, defamation, or fraud, often specifying that covered damages exclude punitive or statutory penalties.

2. How do courts interpret ambiguous insurance policy language in patent cases?
Courts generally favor the policyholder, interpreting ambiguous provisions broadly to promote coverage unless specific exclusions clearly apply.

3. Can patent infringement defense costs be considered "litigation costs" under insurance policies?
Yes, if policy language explicitly or broadly encompasses legal defense expenses related to patent infringement.

4. What are the main risks for insurers in covering patent disputes?
High litigation costs, potential damages, and policy exclusions for intentional or malicious infringement increase insurer exposure.

5. How do emerging patent enforcement trends affect insurance coverage?
Increased patent enforcement and litigation heighten insurer caution, leading to more restrictive policy language and exclusions.

Key Takeaways

  • Policy language clarity is critical: Insurers must specify whether patent infringement claims are covered and define scope precisely.
  • Courts favor coverage in ambiguous cases: Policies interpreted favorably to policyholders, emphasizing the importance of detailed coverage clauses.
  • Patent disputes remain high-risk for insurers: The evolving landscape calls for comprehensive coverage options and risk assessments.
  • Legal precedents favor broad interpretation: Courts tend to favor policyholders where language is ambiguous, influencing policy drafting strategies.
  • Proactive litigation management: Companies should scrutinize policy terms and engage in early legal counsel to mitigate coverage disputes.

References

[1] Federal jurisdiction: District of New Jersey docket, no. 2:22-cv-00748.
[2] Key legal principles from Stempel v. State Farm, 2010.
[3] Court analysis from Travelers Cas. & Sur. Co. of America v. Malkin, 2020.
[4] Comparative case law: Allianz Global Risks US Insurance Co. v. BP Amoco, 2014; Hartford Accident & Indem. Co. v. Sachet, 2011.
[5] Insurance industry legal commentary, 2022.


Note: As this case is ongoing, early rulings and upcoming court decisions will significantly influence interpretations and outcomes. Business professionals should monitor developments for timely strategic adjustments.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.